4.6 Article

Differential signalling pathways for EGF versus PDGF activation of Erk1/2 MAP kinase and cell proliferation in brown pre-adipocytes

Journal

EXPERIMENTAL CELL RESEARCH
Volume 314, Issue 19, Pages 3581-3592

Publisher

ELSEVIER INC
DOI: 10.1016/j.yexcr.2008.09.007

Keywords

EGF; PDGF; Erk1/2; Cell proliferation; Brown adipocytes

Funding

  1. Swedish Cancer Society

Ask authors/readers for more resources

Stimulation by both adrenergic and non-adrenergic pathways can induce proliferation of brown pre-adipocytes. To understand the signalling pathways involved in non-adrenergic stimulation of cell proliferation, we examined Erk1/2 activation. In primary cultures of mouse brown preadipocytes, both EGF(epidermal growth factor) and PDGF(platelet-derived growth factor) induced Erk1/2 activation. EGF-stimulated Erk1/2 activation involved Src tyrosine kinases, but not PKC or PI3K, whereas in PDGF-induced Erk1/2 activation, PI3K, PKC (probably the atypical isoform) and Src were involved sequentially. Both EGF and PDGF induced PI3K-dependent Akt activation that was not involved in Erk1/2 activation. By comparing effects of signalling inhibitors (wortmannin, SH-6, TPA, Go6983, PP2, PD98059) on EGF- and PDGF-induced Erk1/2 activation and cell proliferation (H-3-thymidine incorporation), we conclude that while the signal transduction pathways initiated by these growth factors are clearly markedly different, their effects on cell proliferation can be fully explained through their stimulation of Erk1/2 activation; thus Erk1/2 is a common, essential step for stimulation of proliferation in these cells. (C) 2008 Elsevier Inc. All rights reserved

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available